“…Except less efficiency in vivo (Li & Huang, 2007), the nonviral vector (compared to the viral vector) is a convenient delivery strategy with low toxicity and ease of large-scale production. Cell penetrating peptide (CPP) can transfer various cargos including protein (Choi et al, 2006;ElAndaloussi et al, 2007;Nakase et al, 2008), nuclear acid (Eguchi et al, 2001;Endoh & Ohtsuki, 2009), and the other drug vector (Koppelhus et al, 2008) into a range of cell types as well as the blood-brain barrier (Lindgren et al, 2000). However, the negative charge of siRNA may neutralize the positive charges of CPPs either by covalent attachment (Meade & Dowdy, 2007) or noncovalent conjugated (Veldhoen et al, 2006;Meade & Dowdy, 2008), and result to reduce efficiency of CPP.…”